Single User License: Infectious Diseases In Vitro Diagnostics USD 4315.5 Flat 10% Discount!! (IVD) Market - Global Industry Analysis, Size, Free Customization as per your requirement Share, Trends, Analysis, Growth And You will get Custom Report at Syndicated Report Forecast, 2013 - 2019 price
Transparency Market Research State Tower, 90, State Street, Suite 700. Albany, NY 12207 United States www.transparencymarketresearch.com sales@transparencymarketresearch.com
Report will be delivered with in 15-20 working days
Request Sample
Buy Now
REPORT DESCRIPTION
In vitro diagnostics are the vital tools in health care systems as they provide crucial information for making right medical decisions. The information revealed through these technologies helps physicians in successful management of medical conditions in every stage. Prevalence of infectious diseases such as hepatitis B virus (HBV), hepatitis C virus (HCV), human immunodeficiency virus (HIV), Herpes Simplex Virus (HSV), tuberculosis, measles, dengue, Chagas, cholera, and malaria is increasing across the globe with high prevalence in developing countries. There have been advances in the in vitro diagnostics which have enabled paradigm shift from laboratory testing to point of care testing which is helping in expansion of infectious diseases IVD market. Browse Full Report with TOC: http://www.transparencymarketresearch.com/infectious-diseases-in-vitrodiagnostics.html Some of the major segments in this market include immunochemistry testing, microbiology testing and molecular diagnostics testing. Historically, immunoassays constituted the largest segment in the IVD market which are conducted for determining presence of infectious disease in a patient. Present day technology for testing infection disease include enzyme-linked immunosorbent assay (ELISA) and chemiluminescence immunoassays which require more amount of protein biomarker than molecular diagnostics. However, the market for molecular diagnostics is rapidly growing with the increasing adoption of this technology in place of antigen testing by immunoassays. Molecular diagnostics possess advantages such as high specificity which help detect even minute amount of protein biomarkers. This helps in early detection of infectious diseases and becomes easier to mitigate the result. The global market for infectious disease IVD market is expected to driven by development of newer assays for diagnosis and treatment of infectious diseases. The changing demographics in the world which majorly include aging population and rising incidences of diseases of affluence are propelling the growth of infectious disease IVD market.
On the basis of geography, the global market for infectious disease is segmented into four major regions, namely, North America, Europe, Asia Pacific and Rest of the World. Although industrially developed nations in Europe and North America account for largest share in the global market, high growth is witnessed in the emerging markets of Asia-Pacific regions. The demand for infectious diseases in vitro diagnostics in Asia-Pacific is attributable to high population growth, increasing awareness and investments in healthcare infrastructure. The big players in the market are focusing in this geography to compensate their slowing business in highly competitive western markets. The competitiveness in the industry augmenting each day with more number of players seeking to leverage benefits of this growing market. The leading players in the diagnostic market are acquiring smaller technology companies to produce companion diagnostic tests; while the pharmaceutical companies enticed by the opportunities in the IVD market are either investing or collaborating with diagnostic devices companies to extend their drugs market post patent expiry. Roche Diagnostics and Abbott Laboratories are couple of major companies in the market which have added advantage of synergy between their diagnostic solutions and pharmaceutical solutions. Some of the major companies in the global infectious disease IVD market include Roche Diagnostics, Abbott Laboratories, Becton Dickinson (BD) Company, Gen-Probe, Inc. (a part of Hologic, Inc.), Alere, Inc. (formerly Inverness Medical Innovations, Inc.), Luminex Corporation, Orhto-Clinical Diagnostics (Carlyle Group) LifeScan, Inc. (a Johnson & Johnson company), Siemens Healthcare, bioMeriux SA, and Bio-Rad Laboratories, Inc. This research report analyzes this market depending on its market segments, major geographies, and current market trends.
Geographies analyzed under this research report include
North America
Asia Pacific
Europe
Rest of the World
This report provides comprehensive analysis of
Market growth drivers
Factors limiting market growth
Current market trends
Market structure
Market projections for upcoming years
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.
Reasons for Buying this Report
This report provides pin-point analysis for changing competitive dynamics
It provides a forward looking perspective on different factors driving or restraining market growth
It provides a six-year forecast assessed on the basis of how the market is predicted to grow
It helps in understanding the key product segments and their future
It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
It helps in making informed business decisions by having complete insights of market and by making indepth analysis of market segments
It provides distinctive graphics and exemplified SWOT analysis of major market segments
More Reports on Medical Devices Market: http://www.transparencymarketresearch.com/medical-devicesmarket-reports-6.html About Us
Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.
Contact: Transparency Market Research 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-552-3453 Email: sales@transparencymarketresearch.com Website: http://www.transparencymarketresearch.com/ Browse Market Research Blogs: http://www.tmrblog.com/ https://marketingfirmblog.wordpress.com